1. Home
  2. CRSP vs POWL Comparison

CRSP vs POWL Comparison

Compare CRSP & POWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$55.44

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

N/A

Current Price

$190.60

Market Cap

6.8B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
CRSP
POWL
Founded
2013
1947
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electrical Products
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.8B
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
CRSP
POWL
Price
$55.44
$190.60
Analyst Decision
Buy
Buy
Analyst Count
22
4
Target Price
$87.56
★ $280.00
AVG Volume (30 Days)
★ 1.3M
437.7K
Earning Date
11-09-2026
11-17-2026
Dividend Yield
N/A
★ 0.20%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 3.81
Revenue
$289,590,000.00
★ $448,716,000.00
Revenue This Year
$1,063.30
$7.84
Revenue Next Year
$283.48
$24.55
P/E Ratio
★ N/A
$49.88
Revenue Growth
★ 9169.85
13.34
52 Week Low
$44.12
$167.31
52 Week High
$78.48
$612.50

Technical Indicators

Market Signals
Indicator
CRSP
POWL
Relative Strength Index (RSI) 52.39 44.95
Support Level $50.56 $181.33
Resistance Level $60.04 $185.97
Average True Range (ATR) 2.83 7.03
MACD -0.03 1.59
Stochastic Oscillator 51.06 60.83

Price Performance

Historical Comparison
CRSP
POWL

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

Share on Social Networks: